ProPhase Labs, Inc. Appoints Monica Brady as Chief Accounting Officer
October 02, 2017 at 11:04 am
Share
On September 26, 2017, the board of directors of ProPhase Labs, Inc. appointed Monica Brady as the company’s Chief Accounting Officer, effective October 2, 2017. In this capacity, Ms. Brady will serve as the company’s principal financial officer and principal accounting officer. Ms. Brady has served as the company’s Director of Finance since 2009.
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.
PROPHASE LABS, INC. 
